Literature DB >> 6357401

Level of consciousness after cadaveric kidney transplant under halothane anaesthesia.

P A Casthely, R Villanueva.   

Abstract

Serum and urine bromide levels, serum morphine levels, and postoperative awakening times were observed in 24 patients; 16 undergoing cadaveric kidney transplantation under halothane anaesthesia, eight without preanaesthetic medication (Group A) and eight with morphine preanaesthetic medication (Group B), and eight patients (control) with normal kidney function scheduled for colon resection (Group C). Bromide levels were higher in patients after kidney transplant than in the control group. Transplant patients who did not receive morphine awakened faster after anaesthesia than patients who received 10 mg of morphine 60 minutes before anaesthesia. Morphine levels at the end of anaesthesia were 145 micrograms X 100 ml-1 in Group B; significantly higher than those found in patients with normal kidney function (Group C) (5 +/- 1.05). The majority of the patients undergoing kidney transplantation and receiving morphine for premedication were fully awake 24 hours following surgery despite serum bromide levels of 158 micrograms X ml-1. Control patients had higher awakening scores after surgery than patients in Group A, despite receiving 10 mg of morphine as preoperative medication. Serum bromide levels were far below 480 micrograms X ml-1, the level required to produce clinical symptoms of bromism. The serum and urine bromide levels found in the patients after kidney transplant, even when higher than the control group, were not high enough to explain the prolonged sleepiness found in these patients. The morphine given as preoperative medication may be one of the factors responsible for this finding.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6357401     DOI: 10.1007/bf03015227

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  13 in total

1.  Letter: Bromide concentrations of anesthetists.

Authors:  R E Johnstone; R Andrews; W Brummund
Journal:  Anesthesiology       Date:  1975-07       Impact factor: 7.892

2.  Increased serum bromide concentration after halothane anesthesia in man.

Authors:  R E Johnstone; E M Kennell; M G Behar; W Brummund; R C Ebersole; L M Shaw
Journal:  Anesthesiology       Date:  1975-05       Impact factor: 7.892

3.  The blood-cerebrospinal fluid barrier in uremia.

Authors:  R B FREEMAN; M F SHEFF; J F MAHER; G E SCHREINER
Journal:  Ann Intern Med       Date:  1962-02       Impact factor: 25.391

4.  Metabolism of halothane during and after anaesthesia in man.

Authors:  M M Atallah; I C Geddes
Journal:  Br J Anaesth       Date:  1973-05       Impact factor: 9.166

5.  Protein binding of drugs in plasma from patients with acute renal failure.

Authors:  F Andreasen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1973

6.  Cardiorespiratory effects of anaesthesia with morphine or fentanyl in chronic renal failure and cerebral toxicity after morphine.

Authors:  J W Mostert; J L Evers; G H Hobika; R H Moore; J L Ambrus
Journal:  Br J Anaesth       Date:  1971-11       Impact factor: 9.166

7.  Urinary metabolites of halothane in man.

Authors:  E N Cohen; J R Trudell; H N Edmunds; E Watson
Journal:  Anesthesiology       Date:  1975-10       Impact factor: 7.892

8.  Halothane biotransformation in man: a quantitative study.

Authors:  K Rehder; J Forbes; H Alter; O Hessler; A Stier
Journal:  Anesthesiology       Date:  1967 Jul-Aug       Impact factor: 7.892

9.  Elevation of plasma bromide levels in patients following halothane anesthesia: Time correlation with total halothane dosage.

Authors:  J H Tinker; A J Gandolfi; R A Van Dyke
Journal:  Anesthesiology       Date:  1976-03       Impact factor: 7.892

10.  Halothane biotransformation in anesthetists.

Authors:  P Duvaldestin; R I Mazze; J Hazebrouck; Y Nivoche; S E Cohen; J M Desmonts
Journal:  Anesthesiology       Date:  1979-07       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.